Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | NKTRNektar TherapeuticsFY2025 · Dec |
|---|---|
| Revenue | $55.23M |
| Revenue, yoy | −43.9% |
| Net income | $164.08M |
| Net income, yoy | −37.9% |
| Net margin | -297.1% |
| Free cash flow | $208.68M |
| FCF margin | -377.8% |
| EPS, diluted | $9.73 |
Add another company.